Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Oregon Racing to Block Predatory Hospice Schemes No Photo Available

Hannah Albarazi

As California's revamped laws trigger a massive crackdown on hospice fraud, Oregon lawmakers are moving to protect their residents aga... (more story)

FDA Targets 'Emotional' Ads In New Enforcement Campaign No Photo Available

Dan McKay

Federal regulators' quick objection to a Novo Nordisk commercial touting its new weight loss pill as a chance to "live lighter" is des... (more story)

This Week's Healthcare Earnings: Moderna, Tenet And More No Photo Available

Yeji Jesse Lee

Healthcare stocks saw big moves in recent days, even as earnings season begins to wind down for the industry.